DHPA was among 18 provider and patient advocacy groups that signed onto a letter requesting that the Office of the Inspector General (OIG) issue new guidance indicating that manufacturer copay assistance to federal health program beneficiaries is a violation of the Anti-Kickback Statute when there is a less expensive and equally effective generic or interchangeable […]
Continue Reading >>
Protecting Patient Access to Integrated GI Care in the Independent Setting
In an age when quality of care, cost-effectiveness and transparency are more important than ever, data demonstrates that high-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting.
Provider Groups to GOP Healthy Futures Task Force: Site Neutral Payment Reform Key to Reducing Anti-Competitive Consolidation
DHPA joined the American Academy of Ophthalmology, the American Association of Clinical Urologists, the Infusion Providers Alliance, LUGPA (Large Urology Group Practice Association) and the Outpatient Ophthalmic Surgery Society, in signing a letter to the GOP Healthy Futures Task force with suggestions for policies that would increase competition and reduce anti-competitive consolidation.
Continue Reading >>
Inflammatory Bowel Disease Infographic in English and Spanish
Race-Based Clinical Recommendations in Gastroenterology (AGA)
Within gastroenterology, there is a need to further examine, critique, and reconsider the use of race and ethnicity in clinical decision making. The aim of this article is to define the extent to which race and ethnicity are used in current gastroenterology guideline recommendations. The authors propose recommendations for guideline developers on considering race and […]
Continue Reading >>
DHPA Urges CMS to Rescind Ill-Conceived MFN Interim Final Rule
In a comment letter to the U.S. Centers for Medicare and Medicaid (CMS) regarding the Most Favored Nation (MFN) Interim Final Rule, DHPA wrote that the procedurally, statutorily and constitutionally flawed policy will severely restrict access to life-saving drug treatments and have adverse economic consequences for the Medicare program by shifting care from the more […]
Continue Reading >>
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 10
- Next Page »